Acadia Pharmaceuticals Inc
ACADFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Acadia Pharmaceuticals Inc Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 17 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 29, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| NORTHERN TRUST CORP | 2026-03-31 | 1,272,611 | $28.3M | SEC filing |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2026-03-31 | 10,000 | $223K | SEC filing |
| ALPS ADVISORS INC | 2026-03-31 | 162,820 | $3.62M | SEC filing |
| Logos Global Management LP | 2026-03-31 | 750,000 | $16.7M | SEC filing |
| Sterling Capital Management LLC | 2026-03-31 | 899 | $20K | SEC filing |
| RAYMOND JAMES FINANCIAL INC | 2026-03-31 | 31,923 | $711K | SEC filing |
| MORGAN STANLEY | 2026-03-31 | 1,093,151 | $24.3M | SEC filing |
| MAI Capital Management | 2026-03-31 | 289 | $6.43K | SEC filing |
| MARTINGALE ASSET MANAGEMENT L P | 2026-03-31 | 139,964 | $3.12M | SEC filing |
| Vermillion Wealth Management, Inc. | 2026-03-31 | 14 | $312 | SEC filing |
| CANADA LIFE ASSURANCE Co | 2026-03-31 | 103,314 | Not shown | SEC filing |
| TWO SIGMA INVESTMENTS, LP | 2026-03-31 | 775,121 | $17.3M | SEC filing |
| Rialto Wealth Management, LLC | 2026-03-31 | 8 | $179 | SEC filing |
| Leonteq Securities AG | 2026-03-31 | 1,539 | $34.3K | SEC filing |
| JONES FINANCIAL COMPANIES LLLP | 2026-03-31 | 76,902 | $1.6M | SEC filing |
| Blackstone Inc. | 2026-03-31 | 13,293 | $296K | SEC filing |
| TRUIST FINANCIAL CORP | 2026-03-31 | 26,453 | $589K | SEC filing |
| CANADA PENSION PLAN INVESTMENT BOARD | 2026-03-31 | 68,100 | $1.52M | SEC filing |
| Bay Harbor Wealth Management, LLC | 2026-03-31 | 9 | $200 | SEC filing |
| Rockefeller Capital Management L.P. | 2026-03-31 | 1,027,357 | $22.9M | SEC filing |
- Each value is checked against Acadia Pharmaceuticals Inc's share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 1 row: the filed value is about 1,000 times too small for the share count at Acadia Pharmaceuticals Inc's share price.
120 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Acadia Pharmaceuticals Inc's recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2025-11-10 · Daly James M: Larger than 51 of the 52 other insider sales of Common Stock on file. SEC filing
- 2025-08-18 · Schneyer Mark C.: Larger than 50 of the 52 other insider sales of Common Stock on file. SEC filing
- 2025-06-04 · Brege Laura: Larger than 47 of the 52 other insider sales of Common Stock on file. SEC filing
- 2024-08-19 · DAVIS STEPHEN: Larger than all 52 other insider sales of Common Stock on file. SEC filing
- 2024-04-08 · DAVIS STEPHEN: Larger than 49 of the 52 other insider sales of Common Stock on file. SEC filing
- 2024-03-27 · DAVIS STEPHEN: Larger than 48 of the 52 other insider sales of Common Stock on file. SEC filing
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-26 | Kihara James · PRINCIPAL ACCOUNTING OFFICER | Common Stock | S — Open market or private sale | −11,421 | 26.08 | SEC filing |
| 2026-05-26 | Kihara James · PRINCIPAL ACCOUNTING OFFICER | Common Stock | S — Open market or private sale | −5,401 | 21.18 | SEC filing |
| 2026-05-04 | Kihara James · PRINCIPAL ACCOUNTING OFFICER | Common Stock | S — Open market or private sale | −1,332 | 21.79 | SEC filing |
| 2026-05-04 | Schneyer Mark C. · EVP, CHIEF FINANCIAL OFFICER | Common Stock | S — Open market or private sale | −3,506 | 21.79 | SEC filing |
| 2026-04-07 | Schneyer Mark C. · EVP, CHIEF FINANCIAL OFFICER | Common Stock | S — Open market or private sale | −2,709 | 22.20 | SEC filing |
| 2026-04-07 | Kihara James · PRINCIPAL ACCOUNTING OFFICER | Common Stock | S — Open market or private sale | −1,030 | 22.20 | SEC filing |
| 2026-03-26 | Schneyer Mark C. · EVP, CHIEF FINANCIAL OFFICER | Common Stock | S — Open market or private sale | −37 | 21.72 | SEC filing |
| 2026-03-26 | Schneyer Mark C. · EVP, CHIEF FINANCIAL OFFICER | Common Stock | S — Open market or private sale | −3,171 | 21.65 | SEC filing |
Showing 8 of 10 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-05-29 | HARRIGAN EDMUND · Director | Restricted Stock Units | M — Exercise or conversion of derivative security | −8,107 | SEC filing |
| 2026-05-29 | HARRIGAN EDMUND · Director | Common Stock | M — Exercise or conversion of derivative security | +8,107 | SEC filing |
| 2026-05-29 | Daly James M · Director | Common Stock | M — Exercise or conversion of derivative security | +8,107 | SEC filing |
| 2026-05-29 | GAROFALO ELIZABETH A. · Director | Restricted Stock Units | M — Exercise or conversion of derivative security | −8,107 | SEC filing |
| 2026-05-29 | Poole Jonathan · Director | Restricted Stock Units | M — Exercise or conversion of derivative security | −2,010 | SEC filing |
| 2026-05-29 | Brege Laura · Director | Restricted Stock Units | M — Exercise or conversion of derivative security | −8,107 | SEC filing |
| 2026-05-29 | Daly James M · Director | Restricted Stock Units | M — Exercise or conversion of derivative security | −8,107 | SEC filing |
| 2026-05-29 | Ndu Adora · Director | Restricted Stock Units | M — Exercise or conversion of derivative security | −8,107 | SEC filing |
Showing 8 of 20 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.